Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop

Mov Disord. 1998 Sep;13(5):759-67. doi: 10.1002/mds.870130502.

Authors

S Fahn¹, K E Clarence-Smith, T N Chase

Affiliation

¹ The Neurological Institute, Columbia University, New York, NY, USA.

PMID: 9756143
DOI: 10.1002/mds.870130502

No abstract available

Publication types

Congress
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Nerve Degeneration / drug therapy
Nerve Degeneration / physiopathology*
Neurons / drug effects
Neurons / physiology
Neuroprotective Agents / adverse effects
Neuroprotective Agents / therapeutic use*
Parkinson Disease / drug therapy
Parkinson Disease / physiopathology*
Receptors, Dopamine / drug effects
Receptors, Dopamine / physiology
Research
Substantia Nigra / drug effects
Substantia Nigra / physiopathology

Substances

Neuroprotective Agents
Receptors, Dopamine